Ocugen, Inc. (OCGN)
1.35
-0.01
(-0.74%)
USD |
NASDAQ |
May 21, 16:00
1.345
0.00 (0.00%)
After-Hours: 19:59
Ocugen Research and Development Expense (TTM) : 39.60M for March 31, 2026
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| REGENXBIO, Inc. | 217.03M |
| Catalyst Pharmaceuticals, Inc. | 11.48M |
| Sarepta Therapeutics, Inc. | 896.74M |
| Krystal Biotech, Inc. | 54.64M |
| Gilead Sciences, Inc. | 5.703B |